Reviscon 1.0 % and Reviscon Plus 1.6 %are sterile, non-pyrogenic, clear, non-inflammatory, highly purified sodium hyaluronate of high molecular weight, dissolved in a buffered physiological saline solution. The highly-purified sodium hyaluronate is obtained from bacteria by fermentation.
Reviscon CL 2.0 % is sterile, non-pyrogenic, cross-linked sodium hyaluronate solution. The highly-purified sodium hyaluronate is obtained from bacteria by fermentation.
Reviscon is the products for the relief of the pain and stiffness of the knee joint and other synovial joints in patients with degenerative and traumatic changes to the synovial joint.
All synovial joints especially the weight –bearing joints, contain viscoelastic sodium hyaluronate. This substance has lubrication and shock absorbing properties, allowing these joints to move normally and painlessly. In patients with degenerative joint disease (osteoarthritis), the viscoelasticity of the synovial fluid is significantly impaired, causing the mechanical stress on the joint and the breakdown of the articular cartilage to greatly increase resulting in limited and painful joint movement.
Intraarticular administration of high purity sodium hyaluronate, which has very good viscoelastic properties, can improve the quality of the joint’s lubrication. The lubrication and shock absorbing properties of this product reduce pain and improve joint mobility. This effect may last for several months following a treatment cycle of up to five intraarticular injections.
osteoarthritis knee, osteoarthritis treatment, intra-articular, osteoarthritis of knee, intra articular injection, intra articular injections